Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ibuprofen Extended-Release NDA Slated For 2005, SCOLR Pharma Says

This article was originally published in The Tan Sheet

Executive Summary

SCOLR Pharma plans to file an NDA in summer 2005 for CDT extended-release 12-hour ibuprofen tablets, the firm announced July 26
Advertisement

Related Content

SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth
SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth
SCOLR May File NDA For Ibuprofen Product Following Break With Wyeth
Extended-Release Pseudoephedrine Trial Results “Positive,” SCOLR Says
Extended-Release Pseudoephedrine Trial Results “Positive,” SCOLR Says
Extended-Release Pseudoephedrine Trial Results “Positive,” SCOLR Says
SCOLR IND
SCOLR IND
SCOLR IND

Topics

Advertisement
UsernamePublicRestriction

Register

PS097114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel